|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.20 EUR | -.--% |
|
-.--% | +18.82% |
| Market Cap | 3.85Cr 3.37Cr 3.12Cr 2.88Cr 5.46Cr 368.34Cr 5.57Cr 37Cr 15Cr 180.25Cr 14Cr 14Cr 625.73Cr | P/E 2017 |
17.4x | P/E 2018 | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.67Cr 3.22Cr 2.97Cr 2.75Cr 5.21Cr 351.56Cr 5.31Cr 36Cr 14Cr 172.04Cr 14Cr 13Cr 597.23Cr | EV / Sales 2017 |
1.97x | EV / Sales 2018 | 1.38x |
| Free-Float |
5.42% | Yield 2017 |
3.36% | Yield 2018 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Millet
CEO | Chief Executive Officer | - | 09/12/2002 |
Valérie Chopinet
DFI | Director of Finance/CFO | - | 19/12/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 16/03/1998 | |
Pierre Martin
BRD | Director/Board Member | - | 16/03/1998 |
| Director/Board Member | - | 31/03/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 4.28Cr | ||
| -1.59% | +3.71% | +24.41% | -37.99% | 586.16Cr | ||
| -0.61% | +2.35% | +3.91% | +13.58% | 124.21Cr | ||
| +0.99% | +6.87% | +7.83% | +16.52% | 47Cr | ||
| Average | -0.30% | +4.99% | +12.05% | -2.63% | 190.32Cr | |
| Weighted average by Cap. | -1.26% | +5.30% | +20.03% | -26.17% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 2.19Cr 1.92Cr 1.77Cr 1.64Cr 3.1Cr 209.3Cr 3.16Cr 21Cr 8.27Cr 102.42Cr 8.21Cr 8.03Cr 355.56Cr | 2.22Cr 1.95Cr 1.8Cr 1.66Cr 3.15Cr 212.66Cr 3.21Cr 22Cr 8.4Cr 104.07Cr 8.34Cr 8.16Cr 361.26Cr |
| Net income | 25.42L 22.3L 20.59L 19.02L 36.06L 24Cr 36.78L 2.47Cr 96.16L 12Cr 95.48L 93.38L 41Cr | 16.33L 14.32L 13.22L 12.22L 23.15L 16Cr 23.62L 1.59Cr 61.75L 7.65Cr 61.31L 59.96L 27Cr |
| Net Debt | -10.66L -9L -9L -8L -15.11L -10Cr -15.42L -1.04Cr -40.31L -4.99Cr -40.02L -39.14L -17Cr | -17.52L -15.37L -14.19L -13.11L -24.85L -17Cr -25.35L -1.71Cr -66.28L -8.21Cr -65.8L -64.36L -29Cr |
Employees
-
Sector
Drug Retailers
- Stock Market
- Stocks
- ALINN Stock
Select your edition
All financial news and data tailored to specific country editions
















